Coherus BioSciences is an American biopharmaceutical company focused on developing and commercializing biosimilar drugs.
Coherus BioSciences was founded in 2010 as a pure-play biosimilar company with headquarters in Redwood City, California. The company is publicly traded on the NASDAQ Stock Market with the tag NASDAQ:CHRS.
Coherus develops a type of biologic products called biosimilars.
2016 - Deloitte’s Technology Fast 500 award